2:57 PM
 | 
Nov 14, 2017
 |  BC Innovations  |  Distillery Therapeutics

Cancer

INDICATION: Multiple myeloma (MM)

Cell culture and mouse studies suggest inhibiting EZH2 could help treat KDM6A-mutant MM. In three KDM6A-mutant human MM cell lines, two EZH2 inhibitor tool compounds decreased viability and increased apoptosis compared with an inactive...

Read the full 162 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$18 USD
More Info >